1例雷贝拉唑钠肠溶胶囊致肌张力障碍分析  

One case of dystonia shock caused by Rabeprazole Sodium Delayed-release Capsules

作　　者：董琼 许文成 DONG Qiong;XU Wencheng(Hubei Provincial Hospital of Traditional Chinese Medicine,Affiliated Hospital of Hubei University of Chinese Medicine,Hubei Provincial Academy of Traditional Chinese Medicine,Wuhan 430061,China)

机构地区：[1]湖北省中医院,湖北中医药大学附属医院,湖北省中医药研究院,湖北武汉430061

出　　处：《药学研究》2024年第4期414-416,共3页Journal of Pharmaceutical Research

基　　金：武汉市中青年医学骨干人才培养工程(No.武卫通〔2020〕55号)。

摘　　要：目的提醒临床使用雷贝拉唑钠肠溶胶囊时注意肌张力障碍的不良反应。方法根据患者的临床表现及药物与用药时间的关联性,分析1例由雷贝拉唑钠肠溶胶囊导致的肌张力障碍的病例。结果肌张力障碍可能是雷贝拉唑钠肠溶胶囊新的不良反应。结论临床初次使用雷贝拉唑钠肠溶胶囊的患者应关注肌张力障碍不良反应。Objective To alert clinicians to adverse drug reactions of dystonia induced by Rabeprazole Sodium Delayed-release Capsules.Methods The clinical data of one case of dystonia shock caused by Rabeprazole Sodium Delayed-release Capsules was analyzed while literature related to the drug adverse reactions.Results Dystonia adverse drug reactions are Rabeprazole Sodium Delayed-release Capsules-induced new adverse drug reactions.Conclusion Dystonia adverse reactions should be paid attention to in patients who first use Rabeprazole Sodium Delayed-release Capsule.

关 键 词：雷贝拉唑钠肠溶胶囊 肌张力障碍 药品不良反应 

分 类 号：R969.3[医药卫生—药理学]